Cobalt‐57 bleomycin imaging was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt‐57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt‐57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.
|Original language||English (US)|
|Number of pages||6|
|State||Published - May 1979|
ASJC Scopus subject areas
- Cancer Research